SCHEMBL30937518

SCHEMBL30937518

O=C(O)CN1Cc2cc(F)c(F)cc2NC1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 1/20 0.38
▸ MAPK1 P28482 5/20 0.36
▸ ITGB3 P05106 2/20 0.35
▸ ITGA2B P08514 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ ACE P12821 1/20 0.35
▸ MMP13 P45452 1/20 0.35
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ PER2 O15055 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30937538 0.82 PER2 (0.45) MAPK1ITGB3ITGA2BKDM4EMEN1
SCHEMBL30937552 0.80 PLA2G10 (0.38) DPP4MAPK1PER2PDE4APDE4B
SCHEMBL30937732 0.77 ACE (0.44) DPP4MAPK1KDM4EMEN1ALDH1A1
SCHEMBL30937679 0.75 BRD4 (0.51) KDM4EALDH1A1KMT2AACEMMP13
SCHEMBL30937655 0.74 ALDH1A1 (0.45) MAPK1ITGB3ITGA2BKDM4EMEN1
SCHEMBL30937651 0.74 ACE (0.53) KDM4EMEN1ALDH1A1KMT2ARAB9A
SCHEMBL30937524 0.74 ACE (0.44) MAPK1KDM4EMEN1ALDH1A1KMT2A
SCHEMBL31120591 0.71 ACE (0.45) MAPK1KDM4EMEN1ALDH1A1KMT2A
SCHEMBL30937558 0.71 KDM4E (0.34) MAPK1ITGB3ITGA2BKDM4EMEN1
SCHEMBL6018448 0.70 CA2 (0.41) PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4594307-A1 1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS, INC. (US) 2025-08-06 — — EP disclosed
WO-2024073426-A1 1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS, INC. (US) 2024-04-04 — — WO disclosed
Send feedback